FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001066017 Concept inactivation indicator attribute value reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001067014 Concept inactivation indicator reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001068016 Concept inactivation indicator attribute value reference set (foundation metadata concept) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


141007 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Concept inactivation indicator reference set Is a Attribute value type true Inferred relationship Some

Members valueId
0.58 A component that fails to comply with the current editorial guidance.
0.585 A component that fails to comply with the current editorial guidance.
0.59 A component that fails to comply with the current editorial guidance.
0.6 A component that fails to comply with the current editorial guidance.
0.619 A component that fails to comply with the current editorial guidance.
0.625 A component that fails to comply with the current editorial guidance.
0.63 A component that fails to comply with the current editorial guidance.
0.6386 A component that fails to comply with the current editorial guidance.
0.64 A component that fails to comply with the current editorial guidance.
0.65 A component that fails to comply with the current editorial guidance.
0.67 A component that fails to comply with the current editorial guidance.
0.68 A component that fails to comply with the current editorial guidance.
0.7 A component that fails to comply with the current editorial guidance.
0.72 A component that fails to comply with the current editorial guidance.
0.723 A component that fails to comply with the current editorial guidance.
0.74 A component that fails to comply with the current editorial guidance.
0.75 A component that fails to comply with the current editorial guidance.
0.77 A component that fails to comply with the current editorial guidance.
0.78 A component that fails to comply with the current editorial guidance.
0.79 A component that fails to comply with the current editorial guidance.
0.8 A component that fails to comply with the current editorial guidance.
0.82 A component that fails to comply with the current editorial guidance.
0.85 A component that fails to comply with the current editorial guidance.
0.88 A component that fails to comply with the current editorial guidance.
0.9 A component that fails to comply with the current editorial guidance.
0.92 A component that fails to comply with the current editorial guidance.
0.93 A component that fails to comply with the current editorial guidance.
0.94 A component that fails to comply with the current editorial guidance.
0.95 A component that fails to comply with the current editorial guidance.
0.99 A component that fails to comply with the current editorial guidance.
0.995 A component that fails to comply with the current editorial guidance.
0/5 A component that fails to comply with the current editorial guidance.
00 Buck shot, device Ambiguous
1 A component that fails to comply with the current editorial guidance.
1 Buck shot, device Ambiguous
1 to 12 seizures a year A component that fails to comply with the current editorial guidance.
1 to 7 seizures a week A component that fails to comply with the current editorial guidance.
1 year examination abnormal - for observation A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
1 year examination abnormal - on treatment A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
1 year examination abnormal - referred A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
1,1-Dichloroethylene A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
1,2-Didehydropipecolate reductase A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
1,25-Dihydroxy cholecalciferol A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
1,3-Dichloropropan-2-ol A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
1,3-Diphenylguanidine (DPG) A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
1,4-Diethylene dioxide A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
1,4-Phenylenediamine dihydrochloride A component that fails to comply with the current editorial guidance.
1-Methyl-4-(1-methylethenyl)cyclohexene A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
1-Methylhistidine A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
1-Naphthalene measurement Ambiguous
1-STROKE ENVIRON Moved elsewhere
1.04 A component that fails to comply with the current editorial guidance.
1.042 A component that fails to comply with the current editorial guidance.
1.05 A component that fails to comply with the current editorial guidance.
1.06 A component that fails to comply with the current editorial guidance.
1.08 A component that fails to comply with the current editorial guidance.
1.09 A component that fails to comply with the current editorial guidance.
1.1 A component that fails to comply with the current editorial guidance.
1.14 A component that fails to comply with the current editorial guidance.
1.15 A component that fails to comply with the current editorial guidance.
1.17 A component that fails to comply with the current editorial guidance.
1.2 A component that fails to comply with the current editorial guidance.
1.23 A component that fails to comply with the current editorial guidance.
1.24 A component that fails to comply with the current editorial guidance.
1.25 A component that fails to comply with the current editorial guidance.
1.26 A component that fails to comply with the current editorial guidance.
1.3 A component that fails to comply with the current editorial guidance.
1.33 A component that fails to comply with the current editorial guidance.
1.34 A component that fails to comply with the current editorial guidance.
1.36 A component that fails to comply with the current editorial guidance.
1.39 A component that fails to comply with the current editorial guidance.
1.4 A component that fails to comply with the current editorial guidance.
1.442 A component that fails to comply with the current editorial guidance.
1.45 A component that fails to comply with the current editorial guidance.
1.46 A component that fails to comply with the current editorial guidance.
1.5 A component that fails to comply with the current editorial guidance.
1.5-2.5 hours sent off: [DS4] or [DS1500] Moved elsewhere
1.53 A component that fails to comply with the current editorial guidance.
1.56 A component that fails to comply with the current editorial guidance.
1.563 A component that fails to comply with the current editorial guidance.
1.6 A component that fails to comply with the current editorial guidance.
1.64 A component that fails to comply with the current editorial guidance.
1.66 A component that fails to comply with the current editorial guidance.
1.667 A component that fails to comply with the current editorial guidance.
1.67 A component that fails to comply with the current editorial guidance.
1.68 A component that fails to comply with the current editorial guidance.
1.7 A component that fails to comply with the current editorial guidance.
1.72 A component that fails to comply with the current editorial guidance.
1.75 A component that fails to comply with the current editorial guidance.
1.8 A component that fails to comply with the current editorial guidance.
1.875 A component that fails to comply with the current editorial guidance.
1.876 A component that fails to comply with the current editorial guidance.
1.88 A component that fails to comply with the current editorial guidance.
1.9 A component that fails to comply with the current editorial guidance.
1/2 Halfprin 165mg tablet Moved elsewhere
1/5 A component that fails to comply with the current editorial guidance.
10 A component that fails to comply with the current editorial guidance.
10 day examination abnormal - for observation A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
10 day examination abnormal - on treatment A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
10 day examination abnormal - referred A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
10 mm caliber bullet, device Ambiguous

Start Previous Page 26 of 1411 Next End


Reference Sets

Reference set descriptor

Back to Start